The pharmaceutical sector in Gabon has recorded notable growth, reflecting both increased market demand and expanding infrastructure, according to data from the General Directorate of Economy and Fiscal Policy.
Overall turnover in the sector rose by 4.1%, reaching 76 billion FCFA in 2024 compared with 73 billion FCFA in 2023. The 3 billion FCFA increase marks a steady upward trend in Gabon’s pharmaceutical industry.
This growth has been accompanied by a surge in investment, which climbed 20.5% to reach 470 million FCFA. Funds have been directed towards infrastructure development, renewal of vehicle fleets, and acquisition of new IT equipment, signalling a strong commitment to modernising operations and improving efficiency.
The sector has also experienced workforce consolidation, with employment numbers rising by 4.7% and payrolls increasing by 4.6% as companies recruited additional staff and implemented salary adjustments. This reflects the broader efforts of pharmaceutical companies to strengthen human capital alongside operational capacity.
Industry analysts attribute the sector’s performance to several factors, including the opening of new pharmaceutical structures and the government’s ongoing support for local healthcare initiatives. “The expansion of facilities and investment in modern equipment is directly contributing to the growth of turnover and productivity,” an official from the Directorate commented.
The upward trend also highlights the increasing role of pharmaceuticals in Gabon’s economic landscape, particularly as public health demands continue to evolve. With further investments planned for the coming years, the market is expected to maintain momentum, creating opportunities for local producers and strengthening access to essential medicines across the country.
The data reflects a sector that is not only growing in size but also improving in quality and efficiency, suggesting that Gabon’s pharmaceutical market could play a pivotal role in the nation’s broader economic development strategy.
As the industry continues to modernise and expand, the combination of rising investment, a strengthened workforce, and robust turnover positions Gabon’s pharmaceutical sector as one of the key drivers of economic growth in the healthcare and industrial sectors.
About The Author
